Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential (NCT02183285) | Clinical Trial Compass
CompletedPhase 3
Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential
203 participantsStarted 2003-11
Plain-language summary
To determine the tolerability and safety of Pharmaton PHL 00747 soft gelatine capsules and film-coated tablets
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy female out-patients of child-bearing potential
* Ages ranging between 18 and 40 years
* Willing and able to give written informed consent in accordance to Good Clinical Practice (GCP) and local legislation prior to participation in the study
Exclusion Criteria:
* Contraindications to the use of any of the trial ingredients
* Known hypersensitivity to any of the ingredients
* Alcohol- or drug-addiction
* Currently participation in another trial, or has participated in a trial within the previous 30 days
* Known abnormal values of the laboratory tests (if detected after enrolment, subjects will continue the treatment provided there are no medical objections)
* Already taking other mult-vitamin products during the last 2 weeks
What they're measuring
1
Incidence of total drug-related adverse events assessed by the investigator